Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
株式のランク #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
株価
$25.28
最終同期: 2026-09-18
時価総額
$1.01B
変化(1日)
-2.29%
変化(1年)
-37.84%
GB
取引 GSK plc (GSK)

カテゴリー

GSK plc(GSK)の営業利益率
September 2026 時点の営業利益率 TTM: 24.12%
GSK plc の最新の財務報告と株価によると、現在の営業利益率(TTM)は 24.12% です。2024 年末時点では 18.05% でした。
GSK plc の営業利益率の履歴(2000 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) 24.12% 9.89%
2025 21.95% 21.61%
2024 18.05% -21.73%
2023 23.06% 1.18%
2022 22.79% 4.11%
2021 21.89% -8.79%
2020 24.00% 4.08%
2019 23.06% -11.14%
2018 25.95% -1.78%
2017 26.42% 7.88%
2016 24.49% 31.31%
2015 18.65% -12.40%
2014 21.29% -21.58%
2013 27.15% 10.55%
2012 24.56% -11.72%
2011 27.82% 58.61%
2010 17.54% -41.06%
2009 29.76% -6.09%
2008 31.69% -3.44%
2007 32.82% 1.61%
2006 32.30% 7.45%
2005 30.06% 8.83%
2004 27.62% -7.13%
2003 29.74% 13.64%
2002 26.17% -11.94%
2001 29.72% 13.61%
2000 26.16% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
43.92% -98.18%
US
26.81% -98.89%
US
29.32% -98.78%
US
26.59% -98.90%
CH
16.65% -99.31%
US
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。